News
Scientists challenging conventional beliefs around the genetic risk factors for Alzheimer’s have discovered a genetic link ...
Treatment with memantine in a small cohort of individuals with post-traumatic headache led to fewer average headache days per ...
Synendos Therapeutics appoints Dr. George Garibaldi to move phase 2 clinical development of its lead drug asset SYT-510: Basel, Switzerland Wednesday, July 16, 2025, 15:45 Hrs [IS ...
Synendos Therapeutics (“Synendos”), the clinical-stage biotechnology company developing breakthrough therapies for ...
Overview of Autologous Cell Therapy Product MarketGlobal Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is ...
With clinical trials under pressure, industry leaders say it’s time for reform, digital transformation, and more patient-centric models.
The Canadian Press on MSN6d
Today-Music-History-Jul21Today in Music History for July 21: ...
New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager's wholly- ...
Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...
Questor believes the healthcare sector is looking unloved at the moment. Sven Borho, the co-manager of Worldwide Healthcare ...
With plenty of new pieces and some lost talent due to graduation, here's what Creighton's rotation could look like for the coming season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results